Menu

Recent Interviews

Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464

Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch


Jonathan Summers, CEO, EXMceuticals Inc.

Jonathan Summers
CEO | EXMceuticals Inc.
1111 Alberni Street, Suite 1603, V6E 4V2 Vancouver (CAN)

jonathan@exmceuticals.com

EXMceuticals CEO Jonathan Summers on the medical cannabis market


Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464


Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch

23.12.2019

  • Brokerage

The wallstreet:online group is expanding. A new online broker will expand the business model of the largest online financial community in the German-speaking region. In an interview, Thomas Soltau, member of the Board of Management, explains the strategy for the new "smartbroker". The plans are clearly defined; in the coming years, 200,000 customers are to be acquired for the online transaction business. With FondsDISCOUNT.de, wallstreet:online capital AG has already successfully established a leading independent fund broker on the Internet.

Zum Interview


Jonathan Summers, CEO, EXMceuticals Inc.

Jonathan Summers
CEO | EXMceuticals Inc.
1111 Alberni Street, Suite 1603, V6E 4V2 Vancouver (CAN)

jonathan@exmceuticals.com


EXMceuticals CEO Jonathan Summers on the medical cannabis market

16.12.2019

  • Cannabis

Jonathan Summers is the CEO of EXMceuticals and came on board in the second Quarter of this year. Mr. Summers worked for Goldman Sachs for 15 years, his last role as managing director for corporate finance and is now joining the young cannabis company with his capital markets experience. EXM is currently focused on planting large quantities of cannabis in Africa. EXM plans to sell the refined cannabis products as pure CBD and its components, mainly into Europe, once it has been processed through their R&D laboratory and refinery which is located in Lisbon, Portugal.

Zum Interview